FdaApplication

ANDA 218947

Back to search

Identifiers

Properties

PropertyValue
applicant_nameALKEM LABORATORIES LTD
application_typeANDA
approval_date2024-09-27

Products (2)

ProductActive ingredientStrengthDosage form
CEPHALEXINCEPHALEXINEQ 500MG BASETABLET;ORAL
CEPHALEXINCEPHALEXINEQ 250MG BASETABLET;ORAL

2 products